Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Protective or Curative Element in Type B H. influenzae Rabbit Serum.

The Yale journal of biology and medicine·2011

Same author

Antibody formation in the immunization of human beings.

Federation proceedings·2010

Same author

Spectrophotometric standardization of complement for fixation tests.

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Studies in human malaria; attempts to influence relapsing vivax malaria by treatment of patients with vaccine (Pl. vivax).

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Studies in human malaria; an attempt at vaccination of paretics against blood-borne infection with Pl. vivax.

Journal of immunology (Baltimore, Md. : 1950)·2010

Same author

Studies in human malaria; an attempt at vaccination of volunteers against mosquito-borne infection with Pl. vivax.

Journal of immunology (Baltimore, Md. : 1950)·2010

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

M Heidelberger¹, O T Avery

¹Hospital of The Rockefeller Institute for Medical Research.

The Journal of Experimental Medicine

|October 30, 2009

Summary

Researchers improved methods to purify Pneumococcus specific substances. These polysaccharides, particularly from Type II pneumococcus, remained stable after various precipitation methods, suggesting they are polysaccharide derivatives.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Related Experiment Videos

Last Updated: Jun 19, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Area of Science:

Microbiology
Immunochemistry
Biochemistry

Background:

Pneumococcus specific substances are crucial for serotyping and understanding host-pathogen interactions.
Previous methods for isolating these substances were suboptimal, limiting detailed chemical analysis.

Purpose of the Study:

To refine the purification process for soluble specific substances of Pneumococcus.
To investigate the chemical nature and stability of purified Pneumococcus specific substances, particularly Type II.

Main Methods:

Improved techniques for concentration and purification of Pneumococcus soluble specific substances.
Precipitation of purified Type II pneumococcus substance using immune serum, uranyl nitrate, basic lead acetate, and safranine.
Chemical characterization to compare Type II and Type III pneumococcus substances.

Main Results:

A refined method for concentrating and purifying Pneumococcus soluble specific substances was established.
Highly purified Type II pneumococcus polysaccharide substance showed stability after precipitation with various agents.
Significant chemical differences were observed between Type II and Type III pneumococcus substances, both behaving as polysaccharides.

Conclusions:

The specific substances of Pneumococcus Types II and III are likely polysaccharide derivatives.
The improved purification method allows for more accurate chemical and immunological studies.
Understanding the chemical nature of these substances is vital for their immunological significance.